EUVIMEDEUVIMED entdecken
EditorialOpen Access

EU HTA Joint Clinical Assessment: are patients with rare disease going to lose out?

Alejandra Castanon, Rebecca Sloan, Luisamanda Selle Arocha, Sreeram V Ramagopalan

Journal of Comparative Effectiveness Research · 2024

DOI: 10.57264/cer-2024-0052 ↗

Kurz gefasst

Editorial in der Zeitschrift Journal of Comparative Effectiveness Research, 2024. Verfasst von Alejandra Castanon und 3 weiteren Autor:innen. Beteiligte Einrichtung: Lane Clark & Peacock LLP, London, W1U 9DQ, UK. Hauptthemen laut MEDLINE: Rare Diseases, Technology Assessment, Biomedical. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 12 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The EU HTA guidance should strike a balance between evidential uncertainties and patient access, aligning with the pragmatic approaches of some member states.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Rare DiseasesTechnology Assessment, BiomedicalHumansEuropean Union

Stichwörter der Autor:innen

EU HTAJCARWEindirect comparisonjoint clinical assessmentreal-world evidence

Autor:innen und Institutionen

  • Lane Clark & Peacock LLP, London, W1U 9DQ, UK.
  • Centre for Pharmaceutical Medicine Research, King's College London, London, SE1 9NH, UK.

Zitieren

APA

Castanon, A., Sloan, R., Arocha, L. S., & Ramagopalan, S. V. (2024). EU HTA Joint Clinical Assessment: are patients with rare disease going to lose out?. Journal of Comparative Effectiveness Research. https://doi.org/10.57264/cer-2024-0052

Vancouver

Castanon A, Sloan R, Arocha LS, Ramagopalan SV. EU HTA Joint Clinical Assessment: are patients with rare disease going to lose out?. Journal of Comparative Effectiveness Research. 2024. doi:10.57264/cer-2024-0052

BibTeX
@article{Castanon2024,
  author = {Castanon, Alejandra and Sloan, Rebecca and Arocha, Luisamanda Selle and Ramagopalan, Sreeram V},
  title = {EU HTA Joint Clinical Assessment: are patients with rare disease going to lose out?},
  journal = {Journal of Comparative Effectiveness Research},
  year = {2024},
  doi = {10.57264/cer-2024-0052}
}
Kostenlos starten →